Khan, F.; Tritschler, T.; Kimpton, M.; Wells, P. S.; Kearon, C.; Weitz, J. I.; Büller, H. R.; Raskob, G. E.; Ageno, W.; Couturaud, F.; Prandoni, P.; Palareti, G.; Legnani, C.; Kyrle, P. A.; Eichinger, S.; Eischer, L.; Becattini, C.; Agnelli, G.; Vedovati, M. C.; Geersing, G. -J.; Takada, T.; Cosmi, B.; Aujesky, D.; Marconi, L.; Palla, A.; Siragusa, S.; Bradbury, C. A.; Parpia, S.; Mallick, R.; Lensing, A. W. A.; Gebel, M.; Grosso, M. A.; Shi, M.; Thavorn, K.; Hutton, B.; Le Gal, G.; Rodger, M.; Fergusson, D., Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2021, 19, pp. 2801 - 2813 [articolo]
Noémie Kraaijpoel, Frits I Mulder, Marc Carrier, Annabel van Lieshout, Tom Würdinger, Myron G Best, Bart JM van Vlijmen, Yassene Mohammed, Luis Jara-Palomares, Pieter W Kamphuisen, Marcello Di Nisio, Walter Ageno, Jan Beyer-Westendorf, Thomas Vanassche, Frederikus A Klokm, Hans-Martin Otten, Mike JL Peters, Benilde Cosmi, Marije ten Wolde, Patrick MM Bossuyt, Harry R Büller, Nick van Es, Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study, «THROMBOSIS UPDATE», 2021, 2, pp. 10030 - 10036 [articolo]
Sartori, M.; Favaretto, E.; Cosmi, B., Relevance of immobility as a risk factor for symptomatic proximal and isolated distal deep vein thrombosis in acutely ill medical inpatients, «VASCULAR MEDICINE», 2021, 26, pp. 542 - 548 [articolo]
Gresele, P.; Falcinelli, E.; Bury, L.; Pecci, A.; Alessi, M. -C.; Borhany, M.; Heller, P. G.; Santoro, C.; Cid, A. R.; Orsini, S.; Fontana, P.; De Candia, E.; Podda, G.; Kannan, M.; Jurk, K.; Castaman, G.; Falaise, C.; Guglielmini, G.; Noris, P.; Zaninetti, C.; Fiore, M.; Tosetto, A.; Zuniga, P.; Miyazaki, K.; Dupuis, A.; Hayward, C.; Casonato, A.; Grandone, E.; Mazzucconi, M. G.; James, P.; Fabris, F.; Henskens, Y.; Napolitano, M.; Curnow, J.; Gkalea, V.; Fedor, M.; Lambert, M. P.; Zieger, B.; Barcella, L.; Cosmi, B.; Giordano, P.; Porri, C.; Melazzini, F.; Abid, M.; Glembotsky, A. C.; Ferrara, G.; Russo, A.; Deckmyn, H.; Frelinger, A. L.; Harrison, P.; Mezzano, D.; Mumford, A. D.; Lordkipanidzé, M.; BAT-VAL Study, Investigators, The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2021, 19, pp. 1364 - 1371 [articolo]
Legnani, C.; Palareti, G.; Antonucci, E.; Poli, D.; Cosmi, B.; Falanga, A.; Mastroiacovo, D.; Testa, S., Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register, «BLOOD TRANSFUSION», 2021, 19, pp. 244 - 252 [articolo]
Margaglione M.; Antonucci E.; D'Andrea G.; Migliaccio L.; Ageno W.; Bucherini E.; Cosmi B.; Falanga A.; Martini G.; Mastroiacovo D.; Paparo C.; Poli D.; Testa S.; Palareti G., Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study, «BLOOD TRANSFUSION», 2020, 18, pp. 486 - 495 [articolo]
Favaretto E.; Sartori M.; Pacelli A.; Conti E.; Cosmi B., Coronary artery disease and restenosis after peripheral endovascular intervention are predictors of poor outcome in peripheral arterial disease, «ACTA CARDIOLOGICA», 2020, 75, pp. 649 - 656 [articolo]
Palareti G.; Legnani C.; Antonucci E.; Cosmi B.; Poli D.; Testa S.; Tosetto A.; Ageno W.; Falanga A.; Ferrini P.M.; Pengo V.; Prandoni P.; Prandoni P.; Legnani C.; Poli D.; Prisco D.; Antonucci E.; Ghirarduzzi A.; Veropalumbo M.R.; Ugolotti M.C.; Erba N.; De Micheli V.; Testa S.; Paoletti O.; Luigi S.; Donadini M.; Rancan E.; Quintavalla R.; Santoro R.C.; Orlandini F.; Benedetti R.; Cattaneo M.; Lussana F.; Bertinato E.; Cappelli R.; Pizzini A.M.; D'Angelo A.; Crippa L.; Angeloni L.; Bortolotti R.; Vandelli M.R.; Tripodi A.; Imberti D.; Moia M.; Pesavento R.; Magrini N.; Marongiu F.; Zonzin P.; Piaggesi N.; Silingardi M., D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study, «INTERNAL AND EMERGENCY MEDICINE», 2020, 15, pp. 453 - 462 [articolo]Open Access
Cini, M.; Legnani, C.; Padrini, R.; Cosmi, B.; Dellanoce, C.; De Rosa, G.; Marcucci, R.; Pengo, V.; Poli, D.; Testa, S.; Palareti, G., DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register, «INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY», 2020, 42, pp. 214 - 222 [articolo]
Sartori, Michelangelo; Cosmi, Benilde, Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia, «TH OPEN», 2020, 4, pp. e305 - e308 [articolo]Open Access
Gerotziafas G.T.; Catalano M.; Colgan M.-P.; Pecsvarady Z.; Wautrecht J.C.; Fazeli B.; Olinic D.-M.; Farkas K.; Elalamy I.; Falanga A.; Fareed J.; Papageorgiou C.; Arellano R.S.; Agathagelou P.; Antic D.; Auad L.; Banfic L.; Bartolomew J.R.; Benczur B.; Bernardo M.B.; Boccardo F.; Cifkova R.; Cosmi B.; De Marchi S.; Dimakakos E.; Dimopoulos M.A.; Dimitrov G.; Durand-Zaleski I.; Edmonds M.; El Nazar E.A.; Erer D.; Esponda O.L.; Gresele P.; Gschwandtner M.; Gu Y.; Heinzmann M.; Hamburg N.M.; Hamade A.; Jatoi N.-A.; Karahan O.; Karetova D.; Karplus T.; Klein-Weigel P.; Kolossvary E.; Kozak M.; Lefkou E.; Lessiani G.; Liew A.; Marcoccia A.; Marshang P.; Marakomichelakis G.; Matuska J.; Moraglia L.; Pillon S.; Poredos P.; Prior M.; Salvador D.R.K.; Schlager O.; Schernthaner G.; Sieron A.; Spaak J.; Spyropoulos A.; Sprynger M.; Suput D.; Stanek A.; Stvrtinova V.; Szuba A.; Tafur A.; Vandreden P.; Vardas P.E.; Vasic D.; Vikkula M.; Wennberg P.; Zhai Z.; Bikdeli B.; Guo Y.; Harenberg J.; Hu Y, Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine, «THROMBOSIS AND HAEMOSTASIS», 2020, 120, pp. 1597 - 1628 [articolo]Open Access
Paolisso P.; Bergamaschi L.; D'Angelo E.C.; Donati F.; Giannella M.; Tedeschi S.; Pascale R.; Bartoletti M.; Tesini G.; Biffi M.; Cosmi B.; Pizzi C.; Viale P.; Galie N., Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients, «FRONTIERS IN PHARMACOLOGY», 2020, 11, Article number: 1124, pp. 1124 - 1130 [articolo]Open Access
Palareti G.; Cosmi B., Recensione a: The direct oral anticoagulants may also be effective against the risk of post-thrombotic syndrome, «INTERNAL AND EMERGENCY MEDICINE», 2020, 15, pp. 365 - 367 [recensione]
Drago F.; Gozzo L.; Li L.; Stella A.; Cosmi B., Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence, «FRONTIERS IN PHARMACOLOGY», 2020, 11, Article number: 579886, pp. 1 - 6 [articolo]Open Access
Cini M.; Legnani C.; Testa S.; Tripodi A.; Cosmi B.; Palareti G., An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays, «INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY», 2019, 41, pp. 309 - 315 [articolo]
